Confirming you are not from the U.S. or the Philippines

Ao fornecer esta declaração, declaro e confirmo explicitamente que:
  • Não sou um cidadão nem residente nos EUA
  • Não sou residente nas Filipinas
  • Não possuo, direta ou indiretamente, mais de 10% de ações/direitos de voto/juros dos residentes dos EUA e/ou não controlo cidadãos ou residentes dos EUA por quaisquer outros meios
  • Não tenha propriedade, direta ou indireta, de mais de 10% de ações/direitos de voto/juros e/ou controlo cidadãos ou residentes dos EUA exercidos por outros meios
  • Não sou afiliado de cidadãos ou residentes dos EUA nos termos da Secção 1504(a) da FATCA
  • Tenho consciência da minha responsabilidade por prestar declarações falsas.
Para efeitos da presente declaração, todos os países e territórios dependentes dos EUA são equiparados de igual modo ao território principal dos EUA. Comprometo-me a defender e a considerar isenta a Octa Markets Incorporated, os seus diretores e oficiais relativamente a quaisquer reivindicações que surjam ou estejam relacionadas com qualquer violação da minha declaração no presente documento.
Dedicamo-nos à sua privacidade e à segurança das suas informações pessoais. Coletamos e-mails apenas para fornecer ofertas especiais e informações importantes sobre nossos produtos e serviços. Ao enviar seu endereço de e-mail, você concorda em receber nossas cartas. Se desejar cancelar a assinatura ou tiver alguma dúvida ou preocupação, entre em contato com o nosso Suporte ao Cliente.
Octa trading broker
Abrir conta de negociação
Back

S&P 500 set for record close in 4720s as FDA’s Merck pill approval gives Santa rally additional legs

  • The S&P 500 is up another 0.6% and now more than 4.0% up from Monday lows.
  • The index was given a further boost as the FDA approved Merck’s Covid-19 treatment pill.  

Just before the open of US equity market trade, the US Food and Drug Administration announced that it had approved a second Covid-19 treatment pill for at-home use. Early trials suggest that Merck’s molnupiravir could reduce mortality and hospitalisation rates in at-home patients by as much as 50%. The news comes after the FDA announced on Wednesday that they had approved Pfizer’s paxlovid pill, which early trails showed to have a superior up to 90% efficacy in preventing hospitalisation and death in at-risk patients.

Just as the news of the Pfizer approval helped stoke risk appetite on Wednesday, the announcement prior to the equity open was likely contributed to the S&P 500’s post-open surge. The index, which had moved a tad higher in pre-market trade (according to index futures) and managed to reclaim the 4700 level, opened at 4706 but has since surged into the 4720s. That means the index is up 0.6% on Wednesday’s close in the 4690s and trades just 0.4% below intraday highs printed back on 22 November in the 4740s.

The Nasdaq 100 index is up about 0.5% and the Dow is up about 0.6%, showing that the gains in equity markets are broad-based. The S&P 500 CBOE volatility index (or VIX) fell another half a point and trades at monthly lows close to 18.00. Alongside the news of the recent approval of two at-home Covid-19 treatment pills, risk appetite in US equities has been boosted in recent days by the release of three separate studies (from South Africa, Scotland and London) which all showed Omicron to be significantly milder than Delta.

The news has eased pressure on European authorities to lockdown their economies in order to curb transmission. The S&P 500 index is now more than 4.0% up versus Monday’s lows in the 4530s. If the S&P 500 closes at current levels, that would mark a record closing high just in time for Christmas – bear in mind that US equity markets are shut on Friday. After a bumpy, volatile December, where the S&P 500 index was at one point as much as 5.0% below recent record highs, the “Santa Rally” has finally arrived to save the day.

 

United States EIA Natural Gas Storage Change registered at -55B above expectations (-56B) in December 17

United States EIA Natural Gas Storage Change registered at -55B above expectations (-56B) in December 17
Leia mais Previous

USD/MXN drops below 20.70, to one-month lows

The USD/MXN is trading around 20.65, at the lowest level in a month. A weaker greenback across the board and the risk-on tone across financial markets
Leia mais Next